Details

Autor(en) / Beteiligte

• Castells, Lluis
• Escartín, Alfredo
• Bilbao, Itxarone
• Len, Oscar
• Allende, Helena
• Vargas, Víctor
• Ribera, Esteban
• Lázaro, José-Luis
• Bueno, Javier
• Balsells, Joaquin
• Esteban, Rafael
• Pahissa, Albert
• Margarit, Carlos

Titel

Liver transplantation in HIV-HCV coinfected patients: a case-control study

Ist Teil von

• Transplantation, 2007-02, Vol.83 (3), p.354-358

Ort / Verlag

United States

Erscheinungsjahr

2007

Quelle

MEDLINE

Beschreibungen/Notizen

• Liver transplantation (LT) for hepatitis C virus (HCV)-associated cirrhosis in human immunodeficiency virus (HIV)-infected patients was compared with non-HIV patients. Nine patients with HIV-HCV coinfection were compared with patients transplanted before and after each HIV patient (control group). Immunosuppression consisted in tacrolimus with steroids or mycophenolate mofetil. Acute cellular rejection and three-year actuarial patient survival were respectively 44% and 87.5% in HIV group and 22% and 93.7% in the control group (P=NS). Acute hepatitis C virus occurred earlier (2.3 vs. 4.3 months) and was more cholestatic (mean bilirubin: 10.8 vs. 1.6 mg/dL) in the HIV group. Eight (100%) HIV and nine (64.3%) control patients received antiviral treatment with pegylated interferon and ribavirin. One patient (11.1%) of the control group and one patient (20%) of the HIV group presented a sustained virologic response (P=NS). Short- to midterm results of LT in HIV-HCV co-infected patients were excellent and similar to non-HIV patients.